How do you decide which leads to follow when developing new drugs? Join Dr. Tudor Oprea and Dr. Christopher Lipinski (who formulated the Rule of Five) as they discuss how drug-likeness is a deceiving concept, explore the Rule of Five, and show how lessons from the past may guide the present.
The Fine Print
ACS Webinars® does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.
;void(0);){kind=link}